Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.
Second, we found that metabolic concentrations of plasma LPS are a sufficient molecular mechanism for triggering the high-fat diet-induced metabolic diseases obesity/diabetes. Finally, the LPS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback